Avaii Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Avaii Wealth Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,674	Closed	-$214K	–	187
2026 Q1	$214K	Sell	1,674 -2,765	-62%	-$345K	0.07%	152
2025 Q4	$541K	Sell	4,439 -59	-1%	-$6.76K	0.2%	67
2025 Q3	$451K	Buy	4,498 +1,709	+61%	+$154K	0.17%	82
2025 Q2	$231K	Sell	2,789 -65	-2%	-$5.18K	0.1%	118
2025 Q1	$231K	Sell	2,854 -189	-6%	-$16.9K	0.12%	110
2024 Q4	$274K	Sell	3,043 -37	-1%	-$3.58K	0.13%	105
2024 Q3	$304K	Sell	3,080 -297	-9%	-$29.2K	0.15%	94
2024 Q2	$313K	Sell	3,377 -305	-8%	-$27.3K	0.17%	106
2024 Q1	$349K	Sell	3,682 -188	-5%	-$17.4K	0.21%	91
2023 Q4	$346K	Buy	3,870 +203	+6%	+$15.1K	0.23%	95
2023 Q3	$268K	Buy	+3,667	New	+$293K	0.2%	105

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Avaii Wealth Management's XBI Position: Q2 2026 in Review

Avaii Wealth Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2026, closing a stake of 1,674 shares — an estimated $214K sold.

Avaii Wealth Management first reported a position in XBI in Q3 2023 and held it in 11 quarters. The position peaked at $541K in Q4 2025. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Avaii Wealth Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2026 after selling out during the quarter.
Avaii Wealth Management sold 1,674 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $214K.
Avaii Wealth Management first reported a position in State Street SPDR S&P Biotech ETF in Q3 2023 and held it in 11 quarters.
Avaii Wealth Management's State Street SPDR S&P Biotech ETF position peaked at $541K in Q4 2025.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Avaii Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.